FIELD: chemistry.
SUBSTANCE: invention relates to a ketamine pamoate salt having a stoichiometric ratio of ketamine to pamoate of 2:1, which is a pamoate salt of R, S-ketamine, represented by structural formula (I), a pamoate salt of S-ketamine, represented by structural formula (II), or a pamoate salt of R-ketamine, presented below by structural formula (III). Invention relates to method of treating a disease of the central nervous system (CNS), comprising administering to a subject in need thereof an effective amount of a pharmaceutical composition, where the pharmaceutical composition contains a ketamine pamoate salt according to invention, pharmaceutically acceptable excipient. Invention also relates to anaesthesia of a subject in need thereof, comprising administering to the subject an effective amount of a pharmaceutical composition, where the pharmaceutical composition contains a ketamine pamoate salt according to the invention and a pharmaceutically acceptable excipient thereof.
EFFECT: ketamine pamoate salt for pharmaceutical use.
11 cl, 14 dwg, 8 tbl, 5 ex
(I), 
(II), 
| Title | Year | Author | Number |
|---|---|---|---|
| INJECTABLE COMPOSITIONS OF PROLONGED ACTION OF SALTS OF KETAMINE PAMOATE | 2020 |
|
RU2825874C1 |
| CRYSTALLINE FORMS OF LTA4H INHIBITOR | 2019 |
|
RU2808992C2 |
| CRYSTALLINE FORM AND METHOD OF CLEANING SAME | 2011 |
|
RU2604734C2 |
| CRYSTALLINE FORM OF BENZYL-BENZENE SGLT INHIBITOR | 2011 |
|
RU2569491C2 |
| CRYSTALLINE FORMS OF {[1-CYANO-5-(4-CHLOROPHENOXY)-4-HYDROXY-ISOQUINOLINE-3-CARBONYL]-AMINO}-ACETIC ACID | 2014 |
|
RU2666144C2 |
| CRYSTALS OF CYCLIC AMINE DERIVATIVE AND PHARMACEUTICAL USE THEREOF | 2017 |
|
RU2719384C1 |
| SOLID FORMS OF 3-(5-AMINO-2-METHYL-4-OXO-4H-QUINAZOLIN-3-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND THEIR PHARMACEUTICAL COMPOSITIONS AND USE | 2012 |
|
RU2611007C2 |
| CRYSTAL FORM OF PARP-1 INHIBITOR AND ITS PRODUCTION METHOD | 2018 |
|
RU2792620C2 |
| 5-BROMO-2-(α-HYDROXYPENTYL)BENZOIC ACID SODIUM SALTS IN DIFFERENT CRYSTAL FORMS AND PREPARATION METHOD THEREOF | 2014 |
|
RU2643802C2 |
| POLYMORPHIC MODIFICATIONS OF N-[(3-FLUORO-4-METHOXYPYRIDINE-2-YL)METHYL]-3-(METHOXYMETHYL)-1-({ 4-[(2-OXOPYRIDINE-1-YL)METHYL]PHENYL} METHYL)PYRAZOLE-4-CARBOXAMIDE AND THEIR SALTS | 2017 |
|
RU2756273C2 |
